2ARQ

human plasminogen activator inhibitor-2.[loop (66-98) deletion mutant] complexed with peptide n-acetyl-teaaagdggvmtgr-oh

• Total interactions analyzed: 1
• Total true interactions: 1
• Strongest Interaction:
  • Chains: A-P
  • Int. Res.: 137
  • Norm. En. per Res.: -6.4584
• Hub Node: A(1)

All Interactions

Chains	Hydro. Bond Ener. (kJ/mol)	Elec. Ener. (kJ/mol)	VDW. Ener. (kJ/mol)	Tot. Stab. Ener. (kJ/mol)	#int. res.	# Short cont.	#Hydr. int.	#VDW pairs	#salt bridges	#Pot. fav. elec. int	#Pot. unfav. elec. int
A-P	-318.3284	-27.1278	-539.34	-884.7963	137	36	15	17680	3	19	15

Interface residues

• A-P: ALA201A, ALA332A, ALA338A, ALA347P, ALA348P, ALA349P, ALA358A, ARG166A, ARG195A, ARG337A, ARG346A, ARG358P, ASN127A, ASN200A, ASN334A, ASN339A, ASN347A, ASN363A, ASP191A, ASP193A, ASP331A, ASP348A, ASP351P, ASP361A, GLN176A, GLN357A, GLU124A, GLU132A, GLU315A, GLU316A, GLU319A, GLU346P, GLU353A, GLU364A, GLU365A, GLY131A, GLY179A, GLY188A, GLY192A, GLY206A, GLY336A, GLY350P, GLY352P, GLY353P, GLY357P, GLY366A, GLY45A, HIS317A, HIS356A, ILE169A, ILE181A, ILE309A, ILE35A, ILE398A, LEU122A, LEU123A, LEU129A, LEU15A, LEU184A, LEU185A, LEU198A, LEU256A, LEU30A, LEU314A, LEU320A, LEU324A, LEU349A, LEU351A, LEU407A, LYS128A, LYS178A, LYS180A, LYS205A, LYS207A, LYS313A, LYS335A, MET196A, MET235A, MET264A, MET343A, MET355P, MET359A, MET39A, MET41A, MET54A, PHE130A, PHE137A, PHE158A, PHE204A, PHE212A, PHE29A, PHE312A, PHE333A, PHE340A, PHE350A, PHE355A, PHE396A, PHE408A, PHE409A, PRO182A, PRO186A, PRO32A, SER125A, SER189A, SER31A, SER341A, SER34A, SER352A, SER36A, SER37A, SER46A, THR177A, THR194A, THR345P, THR356P, THR38A, THR50A, TRP172A, TRP208A, TRP33A, TYR121A, TYR141A, TYR203A, TYR258A, TYR318A, VAL126A, VAL173A, VAL190A, VAL197A, VAL199A, VAL202A, VAL262A, VAL354A, VAL354P, VAL360A, VAL362A, VAL42A